Literature DB >> 7381847

Soft drugs. 3. A new class of anticholinergic agents.

N Bodor, R Woods, C Raper, P Kearney, J J Kaminski.   

Abstract

A new class of antimuscarinic drugs was designed and synthesized. The compounds are "soft" quaternary ammonium esters in which there is only one carbon atom separating the ester oxygen and the quaternary head. The compounds are potent anticholinergics when derived from hindered "umbrella" acids and cholinergics when derivatives of simple aliphatic acids. The more potent anticholinergics have up to 10 times higher acetylcholine antagonist activity than atropine, but they have a much shorter duration of action. The compounds cleave hydrolytically with simultaneous destruction of the quaternary head. The compounds are promising as selective, local agents, particularly as inhibitors of eccrine sweating.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7381847     DOI: 10.1021/jm00179a002

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  9 in total

1.  Receptor binding studies of soft anticholinergic agents.

Authors:  F Huang; P Buchwald; C E Browne; H H Farag; W M Wu; F Ji; G Hochhaus; N Bodor
Journal:  AAPS PharmSci       Date:  2001

2.  Design, pharmacokinetic, and pharmacodynamic evaluation of a new class of soft anticholinergics.

Authors:  Fenglei Huang; Clinton E Browne; Whei-Mei Wu; Attila Juhász; Fubao Ji; Nicholas Bodor
Journal:  Pharm Res       Date:  2003-10       Impact factor: 4.200

Review 3.  Designing safer (soft) drugs by avoiding the formation of toxic and oxidative metabolites.

Authors:  Nicholas Bodor; Peter Buchwald
Journal:  Mol Biotechnol       Date:  2004-02       Impact factor: 2.695

4.  Skin structure and metabolism: relevance to the design of cutaneous therapeutics.

Authors:  D A Bucks
Journal:  Pharm Res       Date:  1984-07       Impact factor: 4.200

Review 5.  Chemical delivery systems and soft drugs: Retrometabolic approaches of drug design.

Authors:  Yashumati Ratan Bhardwaj; Ashutosh Pareek; Vivek Jain; Dharma Kishore
Journal:  Saudi Pharm J       Date:  2013-05-09       Impact factor: 4.330

6.  Pharmacokinetic and pharmacodynamic evaluations of the zwitterionic metabolite of a new series of N-substituted soft anticholinergics.

Authors:  Whei-Mei Wu; Peter Buchwald; Nobuhiro Mori; Fubao Ji; JiaXiang Wu; Nicholas Bodor
Journal:  Pharm Res       Date:  2005-09-26       Impact factor: 4.200

7.  Soft drugs. 18. Oral and rectal delivery of loteprednol etabonate, a novel soft corticosteroid, in rats--for safer treatment of gastrointestinal inflammation.

Authors:  N Bodor; T Murakami; W M Wu
Journal:  Pharm Res       Date:  1995-06       Impact factor: 4.200

8.  Soft drugs. 19. Pharmacokinetics, metabolism and excretion of a novel soft corticosteroid, loteprednol etabonate, in rats.

Authors:  N Bodor; W M Wu; T Murakami; S Engel
Journal:  Pharm Res       Date:  1995-06       Impact factor: 4.200

9.  Metabolism, distribution, and transdermal permeation of a soft corticosteroid, loteprednol etabonate.

Authors:  N Bodor; T Loftsson; W M Wu
Journal:  Pharm Res       Date:  1992-10       Impact factor: 4.200

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.